MedTrace Logo

Building Resilience In Caregivers of Trauma Survivors

NCT04293016 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-05-10

No results posted yet for this study

Summary

The purpose of the study is to examine the role of demographics, pre-existing anxiety, depression, and substance use on caregiver depression anxiety, and substance use following a critical injury to a loved one, evaluate the factors that mediate the effectiveness of traditional psychotherapy using problem solving therapy to reduce depression, anxiety, and substance use and to evaluate the factors that mediate the effectiveness of providing an ICU diary and instruction on that diary to reduce depression, anxiety, and substance use.

Conditions

  • Caregiver Burnout

Interventions

BEHAVIORAL

Support as usual

This group receives current best practice which includes participation in ICU support groups and provision of community support resources

BEHAVIORAL

Problem solving therapy

This group will receive one on one therapy based on identifying stressors and solutions to those stressors

BEHAVIORAL

ICU diary

This group will be provided with a structured written diary that includes identification of stressors and development of solutions to those stressors

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Deborah M Little, PhD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2024-08-18
Completion
2024-08-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04293016 on ClinicalTrials.gov